MaxLinear (MXL) Expected to Announce Quarterly Earnings on Thursday

MaxLinear (NASDAQ:MXL) will likely be releasing its Q4 2025 results after the market closes on Thursday, January 29th. Analysts expect the company to announce earnings of $0.18 per share and revenue of $134.82 million for the quarter. Interested persons may review the information on the company’s upcoming Q4 2025 earning report for the latest details on the call scheduled for Thursday, January 29, 2026 at 4:30 PM ET.

MaxLinear (NASDAQ:MXL) last issued its quarterly earnings data on Thursday, October 23rd. The semiconductor company reported $0.14 EPS for the quarter, topping the consensus estimate of $0.12 by $0.02. The business had revenue of $126.46 million during the quarter, compared to analyst estimates of $124.66 million. MaxLinear had a negative net margin of 42.43% and a negative return on equity of 12.74%. The company’s revenue for the quarter was up 56.0% on a year-over-year basis. During the same period in the prior year, the business earned ($0.36) EPS. On average, analysts expect MaxLinear to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

MaxLinear Trading Up 3.0%

Shares of MXL opened at $19.96 on Thursday. MaxLinear has a 1-year low of $8.35 and a 1-year high of $25.73. The company has a current ratio of 1.55, a quick ratio of 1.08 and a debt-to-equity ratio of 0.27. The firm’s 50-day moving average price is $17.25 and its 200-day moving average price is $16.33. The firm has a market capitalization of $1.74 billion, a price-to-earnings ratio of -9.55 and a beta of 1.77.

MaxLinear announced that its Board of Directors has approved a stock buyback program on Monday, November 24th that authorizes the company to repurchase $75.00 million in shares. This repurchase authorization authorizes the semiconductor company to repurchase up to 5.8% of its stock through open market purchases. Stock repurchase programs are typically a sign that the company’s board of directors believes its stock is undervalued.

Insider Buying and Selling

In other news, Director Daniel A. Artusi sold 20,747 shares of the stock in a transaction on Thursday, October 30th. The stock was sold at an average price of $15.39, for a total value of $319,296.33. Following the sale, the director directly owned 12,141 shares of the company’s stock, valued at approximately $186,849.99. This represents a 63.08% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Company insiders own 7.80% of the company’s stock.

Institutional Inflows and Outflows

Several hedge funds have recently modified their holdings of MXL. The Manufacturers Life Insurance Company raised its holdings in shares of MaxLinear by 27.8% during the second quarter. The Manufacturers Life Insurance Company now owns 2,889,111 shares of the semiconductor company’s stock valued at $41,054,000 after purchasing an additional 628,719 shares during the last quarter. Alyeska Investment Group L.P. raised its holdings in MaxLinear by 279.8% during the third quarter. Alyeska Investment Group L.P. now owns 769,349 shares of the semiconductor company’s stock valued at $12,371,000 after acquiring an additional 566,800 shares during the period. Marshall Wace LLP lifted its holdings in MaxLinear by 31.8% in the 3rd quarter. Marshall Wace LLP now owns 1,826,259 shares of the semiconductor company’s stock worth $29,366,000 after purchasing an additional 441,088 shares in the last quarter. Squarepoint Ops LLC bought a new position in MaxLinear in the 2nd quarter worth approximately $5,894,000. Finally, Federated Hermes Inc. grew its holdings in MaxLinear by 243.2% during the 2nd quarter. Federated Hermes Inc. now owns 469,807 shares of the semiconductor company’s stock valued at $6,676,000 after buying an additional 332,932 shares in the last quarter. Hedge funds and other institutional investors own 90.79% of the company’s stock.

Analysts Set New Price Targets

MXL has been the topic of a number of research analyst reports. Weiss Ratings reiterated a “sell (d-)” rating on shares of MaxLinear in a report on Wednesday, October 8th. Benchmark upped their price target on MaxLinear from $25.00 to $28.00 and gave the stock a “buy” rating in a research note on Friday, January 16th. Williams Trading set a $25.00 price objective on MaxLinear in a report on Friday, October 24th. Finally, Stifel Nicolaus set a $23.00 target price on shares of MaxLinear in a report on Friday, October 24th. Two equities research analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Hold” and a consensus price target of $19.29.

About MaxLinear

MaxLinear, Inc is a provider of radio-frequency (RF), analog, and mixed-signal integrated circuits for broadband communications, data center connectivity, and video infrastructure applications. The company’s product portfolio includes high-performance RF front-end modules, broadband power amplifiers, optical and Ethernet transceivers, and network processors designed to support demanding signal processing requirements.

MaxLinear’s semiconductor solutions are used by cable and satellite television operators, fiber-to-the-home service providers, network equipment manufacturers, and data center operators.